Erythromycin resistance in group A beta hemolytic streptococcus

被引：6

作者：

Esposito, S

Noviello, S

Ianniello, F

D'Errico, G

机构：

[1] Univ Naples 2, Clin Malattie Infett, Osped Gesu & Maria, Dept Infect Dis, I-80135 Naples, Italy

[2] Univ Naples 2, Dept Otorhinolaryngol, Naples, Italy

来源：

CHEMOTHERAPY | 1998年 / 44卷 / 06期

关键词：

group A streptococcus; macrolides; resistance; phenotype;

D O I：

10.1159/000007148

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

The incidence of erythromycin resistance and the phenotypic pattern of resistance have been studied in 130 group A beta-hemolytic streptococcus (GABHS) strains, isolated from throat swab obtained in children affected by acute pharyngotonsillitis. A total of 56 (43%) GABHS strains of 130 were resistant to erythromycin. Among these 56 strains, we found that 7 (12.5 %), 18 (32.1%) and 31 (55.3%) showed the cMLS, iMLS and M phenotype, respectively. The iMLS and M phenotypes appear to be the most widely represented ones. Their low level of resistance to macrolides could allow the use of the more recent macrolides characterized by higher tissue concentration which could overcome such a resistance.

引用

页码：385 / 390

页数：6

共 22 条

[1] GROUP-A STREPTOCOCCAL INFECTIONS AND ACUTE RHEUMATIC-FEVER [J].

BISNO, AL .

NEW ENGLAND JOURNAL OF MEDICINE, 1991, 325 (11) :783-793

[2] THE RESURGENCE OF ACUTE RHEUMATIC-FEVER IN THE UNITED-STATES [J].

BISNO, AL .

ANNUAL REVIEW OF MEDICINE, 1990, 41 :319-329

[3] DEFINING THE GROUP-A STREPTOCOCCAL TOXIC SHOCK SYNDROME - RATIONALE AND CONSENSUS DEFINITION [J].

BREIMAN, RF ;

DAVIS, JP ;

FACKLAM, RR ;

GRAY, BM ;

HOGE, CW ;

KAPLAN, EL ;

MORTIMER, EA ;

SCHLIEVERT, PM ;

SCHWARTZ, B ;

STEVENS, DL ;

TODD, JK .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1993, 269 (03) :390-391

[4]

CIPRIANI P, 1995, MICROBIOL MED, V10, P171

[5]

CRISTIANO L, 1996, MICROBIOL MED, V11, P30

[6] PREVENTION OF RHEUMATIC-FEVER - A STATEMENT FOR HEALTH-PROFESSIONALS BY THE COMMITTEE ON RHEUMATIC-FEVER, ENDOCARDITIS, AND KAWASAKI DISEASE OF THE COUNCIL ON CARDIOVASCULAR-DISEASE IN THE YOUNG, THE AMERICAN HEART ASSOCIATION [J].

DAJANI, AS ;

BISNO, AL ;

CHUNG, KJ ;

DURACK, DT ;

GERBER, MA ;

KAPLAN, EL ;

MILLARD, HD ;

RANDOLPH, MF ;

SHULMAN, ST ;

WATANAKUNAKORN, C .

CIRCULATION, 1988, 78 (04) :1082-1086

[7] PREVENTION OF RHEUMATIC FEVER - TREATMENT OF THE PRECEDING STREPTOCOCCIC INFECTION [J].

DENNY, FW ;

WANNAMAKER, LW ;

BRINK, WR ;

RAMMELKAMP, CH ;

CUSTER, EA .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1950, 143 (02) :151-153

[8]

GASTANADUY AS, 1980, LANCET, V2, P498

[9] DECREASED ACTIVITY OF ERYTHROMYCIN AGAINST STREPTOCOCCUS-PYOGENES IN TAIWAN [J].

HSUEH, PR ;

CHEN, HM ;

HUANG, AH ;

WU, JJ .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1995, 39 (10) :2239-2242

[10]

KAVEY REW, 1989, PEDIATRICS, V84, P585

← 1 2 3 →